New Advances in Cellular Therapy for Scleroderma: CAR-T and Stem Cells - George Georges, MD

This was presented at the Fall Scleroderma Patient Education Conference, held on October 18, 2025, hosted by the Scleroderma Foundation of Greater Chicago in Chicago, IL. Groundbreaking advances in cellular therapy are transforming the treatment landscape for scleroderma. In this cutting-edge presentation, George Georges, MD, provides a comprehensive review of the current status and future directions of cellular therapies for systemic sclerosis (SSc). If you or a loved one is navigating treatment options for this challenging autoimmune disease, this session offers essential insights into the most promising innovations on the horizon. Dr. Georges covers: ✅ Chimeric Antigen Receptor T cell (CAR-T) therapy: How this revolutionary approach is being applied to autoimmune diseases like scleroderma ✅ Hematopoietic stem cell transplantation (HSCT): Current status, patient selection, and outcomes ✅ Comparing cellular therapy approaches for systemic sclerosis ✅ Future directions in clinical research for autoimmune diseases ✅ What these advances mean for patients and caregivers Why this matters: For patients with severe systemic sclerosis, cellular therapies such as HSCT and emerging CAR-T approaches offer the potential for deep, durable responses—and in some cases, disease modification that goes beyond traditional immunosuppressive treatments. Understanding these options is critical for informed decision-making. About the Speaker: George Georges, MD is a leading expert in cellular therapy and transplantation, dedicated to advancing treatment options for patients with systemic sclerosis and other autoimmune diseases. To learn more about scleroderma and the foundation, head to www.stopscleroderma.org. To view the slides and follow along at your own pace at: https://www.slideshare.net/slideshow/...   / stopscleroderma   #Scleroderma #CellularTherapy #CARTTherapy #StemCellsAndScleroderma #HSCT #SystemicSclerosis #AutoimmuneDisease #CARTForAutoimmune #StemCellTransplantation #SclerodermaTreatment #MedicalInnovation #PatientEducation